Evidence map›Paper›PMID 16501571›Full record

ArticleNature medicine2006

Viral nanoparticles as tools for intravital vascular imaging.

John D Lewis, Giuseppe Destito, Andries Zijlstra, Maria J Gonzalez, James P Quigley, Marianne Manchester, Heidi Stuhlmann

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 334 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Self-assembled Viral Nanoparticles as Targeted Anticancer Vehicles.Biotechnology and bioprocess engineering : BBE · 2021
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. FunctionalizedCancers · 2019
    Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

John D LewisDepartment of Cell Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Giuseppe Destito
Andries Zijlstra
Maria J Gonzalez
James P Quigley
Marianne Manchester
Heidi Stuhlmann
Scripps Research Institute · US

Funding

Transmembrane Proteins Involved in Human Tumor ExpansionR01CA105412 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI QUIGLEY, JAMES P · 2004 to 2020
$5.8M
USING VIRAL NANOPARTICLES TO TARGET CANCERR01CA112075 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MANCHESTER, MARIANNE · 2005 to 2009
$3.7M
MATRIX METALLOPROTEASES IN TUMOR CELLSR01CA055852 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI QUIGLEY, JAMES P · 1992 to 2009
$2.9M
PLANT VIRUS CHIMERAS AS VACCINES AND ANTIVIRALSR01AI047823 · NIAID · SCRIPPS RESEARCH INSTITUTE · PI MANCHESTER, MARIANNE · 2000 to 2003
$1.6M
FUNCTIONAL ANALYSIS OF VEFZ1, A NOVEL ENDOTHELIAL MARKERR01HL065738 · NHLBI · SCRIPPS RESEARCH INSTITUTE · PI STUHLMANN, HEIDI · 2000 to 2003
$1.4M
Marking Progenitor Cell Lineages in the Vascular SystemR21HL072270 · NHLBI · SCRIPPS RESEARCH INSTITUTE · PI STUHLMANN, HEIDI · 2002 to 2004
$833k
NCI NIH HHS CA112075NCI NIH HHS N01-CO-27181NCI NIH HHS R01 CA055852NCI NIH HHS R01 CA105412NCI NIH HHS R01 CA112075NCI NIH HHS R01 CA55852NHLBI NIH HHS R01 HL065738NHLBI NIH HHS R01 HL65738NHLBI NIH HHS R21 HL072270NHLBI NIH HHS R21 HL72270NIAID NIH HHS AI47823NIAID NIH HHS R01 AI047823
6 · The paper itself

Abstract

A significant impediment to the widespread use of noninvasive in vivo vascular imaging techniques is the current lack of suitable intravital imaging probes. We describe here a new strategy to use viral nanoparticles as a platform for the multivalent display of fluorescent dyes to image tissues deep inside living organisms. The bioavailable cowpea mosaic virus (CPMV) can be fluorescently labeled to high densities with no measurable quenching, resulting in exceptionally bright particles with in vivo dispersion properties that allow high-resolution intravital imaging of vascular endothelium for periods of at least 72 h. We show that CPMV nanoparticles can be used to visualize the vasculature and blood flow in living mouse and chick embryos to a depth of up to 500 microm. Furthermore, we show that the intravital visualization of human fibrosarcoma-mediated tumor angiogenesis using fluorescent CPMV provides a means to identify arterial and venous vessels and to monitor the neovascularization of the tumor microenvironment.

Indexed as

AnimalsArteriesChick EmbryoChorioallantoic MembraneComovirusDiagnostic ImagingEndothelium, VascularFluorescent DyesHumansMiceMicrocirculationNanostructuresNeoplasmsNeovascularization, PathologicPolyethylene GlycolsTime FactorsFluorescent DyesPolyethylene Glycols

Identifiers

PMID16501571
PMCPMC2536493
OpenAlexW2150635644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.